Law firm Lifshitz, PC announces cassava investigations

NEW YORK, December 23, 2021 (GLOBE NEWSWIRE) –
Cassava Sciences, Inc. (NASDAQCM: SAVA)
Lifshitz Law Firm, PC announces that a class action lawsuit has been filed against Cassava, alleging that the defendants made false and misleading statements and failed to disclose that: (i) the quality and integrity of the scientific data supporting Cassava Sciences’ claims regarding the efficacy of simulfilam had been overestimated; (ii) the scientific data supporting Cassava Sciences’ claims regarding the efficacy of simulfilam were biased; and (iii) accordingly, the defendants ‘affirmative statements during the Class Period regarding Cassava Sciences’ business actions and financial prospects and the likelihood of US Food Drug Administration (“FDA”) approval were false. and misleading and / or lacked a reasonable basis. .
If you are a cassava investor and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]
HyreCar, Inc. (NASDAQCM: HYRE)
Lifshitz Law Firm, PC announces that a class action lawsuit has been filed on behalf of the shareholders of HyreCar, alleging that the defendants made false and misleading statements and did not disclose that: (i) HyreCar had substantially underestimated its insurance reserves; (ii) HyreCar consistently failed to pay valid insurance claims incurred prior to the Class Period; (iii) HyreCar had incurred significant expenses in transitioning to its new insurance claims administrator and handling claims incurred in previous periods; (iv) HyreCar had not correctly priced the risk in its insurance products and suffered a high incidence of claims as a result; (v) HyreCar had been forced to radically reform its underwriting, policies and complaints procedures in response to unacceptable severity of claims and customer complaints; and (vi) as a result, HyreCar’s operations and outlook were distorted as HyreCar was not on track to meet the financial estimates provided to investors during the Class Period, and those estimates lacked a basis reasonable in fact, including HyreCar’s purported gross margin, earnings before interest, taxes, depreciation and amortization (“EBITDA”) and net loss trajectories.
If you are a HyreCar investor and would like additional information about our survey, please complete the Information Request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]
LoanDepot, Inc. (NYSE LDI)
Lifshitz Law Firm, PC announces that a class action lawsuit has been filed against LDI alleging that the defendants failed to disclose to investors: (1) that the company’s refinancing operations had already declined significantly at the time of the filing on the stock market due to industry overcapacity and increasing competition; (2) that the profit margins on the sale of the Company had already considerably diminished at the time of the IPO; (3) that as a result, the revenues and growth of the Company would be adversely affected; and (4) that as a result of the foregoing, the Defendants’ positive statements regarding the business, operations and prospects of the Company were materially misleading and / or lacked reasonable basis.
If you are an LDI investor and would like additional information about our investigation, please complete the information request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]
Longeveron Inc. (NASDAQCM: LGVN)
Lifshitz Law Firm, PC announces that a class action lawsuit has been filed against LGVN alleging that the Offer Documents and the Defendants made false and / or misleading statements and / or failed to disclose that: (i) Lomecel- B was not as effective in treating aging frailty as the defendants had led investors to believe; (ii) as a result, the clinical and commercial prospects of Lomecel-B with regard to the frailty of aging have been overestimated; and (iii) accordingly, the Offer Documents and the public statements of the Defendants throughout the Class Period were materially false and / or misleading and did not indicate the information to be contained therein.
If you are an LGVN investor and would like additional information about our investigation, please complete the Information Request form or contact Joshua Lifshitz, Esq. by phone at (516)493-9780 or by email at [email protected]
LAWYER ADVERTISING.© 2021 Lifshitz Law Firm, PC The law firm responsible for this announcement is Lifshitz Law Firm, PC, 1190 Broadway, Hewlett, New York 11557, Tel. : (516) 493-9780. Past results do not guarantee or predict a similar result with respect to any future matters.
Contact:
Joshua M. Lifshitz, Esq.
Law firm Lifshitz, CP
Telephone: 516-493-9780
Fax: 516-280-7376
E-mail: [email protected]